Activation of this pathway creates an inflammatory, insulin‐resistant, obesogenic and immune‐disrupted microenvironment, which is crucial to the development of metabolic diseases like T2D [6, 7]. This evidence concerns the gene INS and type 2 diabetes mellitus.